Free Trial

Procyon Advisors LLC Buys Shares of 4,569 Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Procyon Advisors LLC bought a new position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor bought 4,569 shares of the business services provider's stock, valued at approximately $370,000.

Several other large investors have also made changes to their positions in EXPO. Raymond James Financial Inc. acquired a new position in shares of Exponent during the 4th quarter worth approximately $55,131,000. Norges Bank acquired a new position in shares of Exponent during the 4th quarter worth approximately $52,381,000. Resona Asset Management Co. Ltd. acquired a new position in shares of Exponent during the 4th quarter worth approximately $38,538,000. BLI Banque de Luxembourg Investments acquired a new position in shares of Exponent during the 4th quarter worth approximately $12,564,000. Finally, Barclays PLC raised its stake in shares of Exponent by 88.5% during the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after buying an additional 85,395 shares during the period. 92.37% of the stock is owned by institutional investors and hedge funds.

Exponent Stock Down 1.6%

Shares of EXPO stock traded down $1.25 during trading hours on Wednesday, hitting $76.22. 191,936 shares of the company's stock were exchanged, compared to its average volume of 250,769. The firm has a market cap of $3.87 billion, a P/E ratio of 35.95 and a beta of 0.92. The firm has a 50 day moving average of $77.96 and a two-hundred day moving average of $85.16. Exponent, Inc. has a fifty-two week low of $73.37 and a fifty-two week high of $115.75.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The firm had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. During the same period in the prior year, the company earned $0.59 EPS. The firm's revenue was up .2% compared to the same quarter last year. On average, equities analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's dividend payout ratio is currently 58.54%.

Insider Activity at Exponent

In other Exponent news, VP Joseph Rakow sold 1,573 shares of the company's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP John Pye sold 2,000 shares of the company's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the completion of the sale, the vice president now owns 29,204 shares of the company's stock, valued at approximately $2,228,849.28. The trade was a 6.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,267 shares of company stock valued at $489,120. 2.10% of the stock is owned by insiders.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Featured Stories

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines